A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. By inducing the down-regulation of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in the ileum, post-ABX gut recolonization by Enterocloster species drove the emigration of enterotropic α4β7 + CD4 + regulatory T 17 cells into the tumor. These deleterious ABX effects were mimicked by oral gavage of Enterocloster species, by genetic deficiency, or by antibody-mediated neutralization of MAdCAM-1 and its receptor, α4β7 integrin. By contrast, fecal microbiota transplantation or interleukin-17A neutralization prevented ABX-induced immunosuppression. In independent lung, kidney, and bladder cancer patient cohorts, low serum levels of soluble MAdCAM-1 had a negative prognostic impact. Thus, the MAdCAM-1–α4β7 axis constitutes an actionable gut immune checkpoint in cancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intestinal dysbiosis, broadly defined as an imbalance in the composition or function of the gut microbiota, is a significant contributor to resistance against immune checkpoint inhibitor (ICI) therapies.1–16,”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Antibiotics predictably inflict the most acute damage, reducing diversity, depleting beneficial commensals, and permitting blooms of pathobionts like Enterocloster and Streptococcus.4,27,98”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“For instance, our lab has shown that antibiotic-induced dysbiosis spurs the downregulation of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1; discussed below) via altered BA metabolism (Fig. 3h).4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Our lab recently reported that low baseline sMAdCAM-1 levels are strongly associated with gut dysbiosis in cancer patients.4,24”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“This, in turn, allows immunosuppressive gut-resident α4β7+FoxP3+ regulatory Th17 (Tr17) cells to exit the gut and migrate to peripheral tumors, where they can blunt local antitumor immunity.4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Self-citationQuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447 · cited 1×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 3×
“Moreover, FMT from some human donors fails to improve ICI responses (7, 35).”
BackgroundMethodSelf-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496 · cited 2×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
BackgroundMethodVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 1×
“, A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)fucosyltransferase-IV.”
BackgroundMultivariable association discovery in population-scale meta-omics studies
Mallick, H., Rahnavard, A., McIver, L. J., Ma, S., Zhang, Y., Nguyen, L. H., Tickle, T. L., Weingart, G., Ren, B., Schwager, E. H., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009442 · Cited by 2,596
Cited by
Items 101–200 of 244
Pamungkas, K. M. N., Dewi, P. I. S. L., Alamsyah, A. Z., Dewi, N. L. P. Y., Dewi, N. N. G. K., Mariadi, I. K., & Sindhughosa, D. A. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.106810 · Cited by 11
Vilbert, M., Koch, E. C., Rose, A. A. N., Laister, R. C., Gray, D., Sotov, V., Penny, S. L., Spreafico, A., Hogg, D., Pinto, D. M., et al. (2023) · Cancers · doi:10.3390/cancers15143708 · Cited by 10
Curcumin derived functional carbon quantum dots for enhanced tumor theranostic
Zhang, G., Kang, C., Chen, H., Tian, W., & Liu, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160594 · Cited by 8
Rousseau, A., Simon‐Tillaux, N., Michiels, S., Derosa, L., Laparra, A., Planchard, D., Remón, J., Barlési, F., Lavaud, P., Frélaut, M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.29225 · Cited by 13
Self-citationJia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
Immunotherapy efficacy and toxicity: Reviewing the evidence behind patient implementable strategies
Verhaert, M., & Aspeslagh, S. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114235 · Cited by 11
Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insights
Mager, L. F., Krause, T., & McCoy, K. D. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.03.007 · Cited by 8
The Microbiome and Genitourinary Cancers: A New Frontier
Winslow, T. B., Gupta, S., Vaddaraju, V., Guercio, B. J., & Sahasrabudhe, D. M. (2025) · Cancers · doi:10.3390/cancers17223606 · Cited by 7
Microbiota-derived metabolites as modulators of cancer immunotherapy response
Toner-Bartelds, C., Mimpen, I. L., Parra-Martinez, M., Burgering, B. M. T., & Voest, E. E. (2026) · Nature Communications · doi:10.1038/s41467-026-72178-1 · Cited by 10
Impact of gut microbiota and its metabolites on immunometabolism in colorectal cancer
Flory, M., Bravo, P., & Alam, A. M. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000050 · Cited by 11
Link between respiratory microbiota and asthma: an emerging therapeutic approach
Tian, C., Li, X., Yuan, X., & Li, Z. (2024) · American Journal of Translational Research · doi:10.62347/osnz1705 · Cited by 10
Hadjigeorgiou, A. G., Harkos, C., Mishra, A. K., Morad, G., Johnson, S. B., Ajami, N. J., Wargo, J. A., Munn, L. L., Stylianopoulos, T., & Jain, R. K. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2232 · Cited by 17
The gut microbiome in lung cancer: from pathogenesis to precision therapy
Shi, M. K., Wang, L., Hu, W., & Liang, Z. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1606684 · Cited by 8
Unveiling the interplay between microbiota and PD1/PD-L1 axis in tumor immunity and immunotherapy
Lu, Q., Wu, J., Yu, X., Qian, J., & Song, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690374 · Cited by 6
Wang, Z., Wang, Z., Jiang, J., Yang, L., Li, C., Deng, X., Li, Y., Yuan, J., Jiang, P., & Wang, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02600-1 · Cited by 9
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling
Suissa, D., Fidelle, M., Reich, E., Pham, T.-N., Thomas, S., Björk, J. R., Liu, P., Zhao, L., Kitaoka, K., Piard, E., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04481-9 · Cited by 10
Self-citationChen, Y., Che, X., Rong, Y., Zhu, J., Yu, Y., Xu, H., Sun, Y., Chen, H., Yan, L., Chen, L., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112366 · Cited by 7
Wu, B., Quan, C., He, Y., Matsika, J., Huang, J., Liu, B., & Chen, J. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2371543 · Cited by 7
Self-citationMicrobiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 9
Microbiota interaction with Tregs: a target for colitis
Mortezaee, K. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-03974-2 · Cited by 8
Zhao, M., Tian, J., Hou, W., Yin, L., & Li, W. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1416385 · Cited by 6
Silva, C. A. C., Almonte, A. A., & Zitvogel, L. (2025) · Biomolecules · doi:10.3390/biom15040504 · Cited by 6
Self-citationGut microbiota drives cancer evolution and therapy resistance
Min, S., Zhang, Y., Zhang, H., & Liu, Q. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02564-8 · Cited by 10
The Gut–Brain–Immune Axis in Glioma: Emerging Mechanisms and Therapeutic Opportunities
Feng, R., Yang, Z., Zhou, Y., & Zhao, H. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01680-3 · Cited by 8
Ren, X., Zheng, G., Liu, Y., Li, S., Liu, S., Wen, Y., Zhang, Y., Zhao, Y., Guan, H., Wang, X., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.01.020 · Cited by 7
MAdCAM-1: a newly identified microbial 'gut check' for T cells
Chelvanambi, M., & Wargo, J. A. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.06.007 · Cited by 5
Kong, D., Wu, Y., Liu, Q., Huang, C., Wang, T., Huang, Z., Gao, Y., Li, Y., & Guo, H. (2024) · European journal of medical research · doi:10.1186/s40001-024-01814-7 · Cited by 5
Monyók, Á., Mansour, B., Vadnay, I., Makra, N., Dunai, Z. A., Nemes-Nikodém, É., Stercz, B., Szabó, D., & Ostorházi, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084562 · Cited by 6
Johnson, S. D., Pino, M., Acharya, A., Clain, J. A., Bose, D., Nguyen, K., Harper, J. L., Villinger, F. J., Paiardini, M., & Byrareddy, S. N. (2025) · JCI Insight · doi:10.1172/jci.insight.184491 · Cited by 6
Jacobsen, G. E., Gonzalez-Horta, E. E., Mendygral, P. O., Faust, K. M., Hazime, H., Fernández, I., Santander, A. M., Quintero, M. A., Jiang, C., Damas, O. M., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae316 · Cited by 5
Siglec-7 and -15 recognize repeated clustered sulfo-sialo O-glycan motifs on select O-glycoproteinsPreprint
Goerdeler, F., Hornikx, D. L. A. H., Valckx, V. T. C., Chien, Y.-C., de Wit, D., Jaroentomeechai, T., Jaeger, M., Furukawa, S., Tseng, H.-C., Jung, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.07.698156 · Cited by 6
Qiao, T., & Zhu, Z. (2025) · Microorganisms · doi:10.3390/microorganisms13112595 · Cited by 9
Respiratory microbiome-host interaction on lung carcinogenesis, immunity, and immunotherapy
Wang, P., Ge, C., Jing, X., Han, Q., Wang, M., Huang, M., & Xiang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676302 · Cited by 7
Li, D., Dian, Y., Li, L., Du, S., Meng, Y., Yao, L., Zhou, Q., Xiong, Y., Sun, Y., Su, H., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2623986 · Cited by 5
The role of the microbiota in cancer drug resistance and emerging therapeutic strategies
Che, C., Zhou, Y., Chen, L., Li, S., fan, D., Lu, Y., & Zhao, X. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218305 · Cited by 6
Defensive remodeling of gut microbiota under microplastic stress and its pathogenic mechanism
Jian, P., Zhang, F., Chen, Z., Zhou, X., Xiong, Y., Hu, Q., Wang, Y., Li, D., Yan, J., Yang, J., et al. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112145 · Cited by 4
Lin, Z., Mu, S., Zhang, W., Guo, Y., Dong, C., Song, L., Zhang, H., Wu, R., Luo, P., & Liang, L. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102428 · Cited by 4
Microbiome dynamics in immune checkpoint blockade
Kim, C. W., Kim, H.-J., & Lee, H. K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.013 · Cited by 5
Liu, T., Gu, Y., Zhang, Y., & Li, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1439709 · Cited by 4
Wang, G. Q., Gong, H., Zou, Y., Zhang, H., & Mao, X. (2025) · Nutrients · doi:10.3390/nu17101610 · Cited by 8
Zeo-Sánchez, D. E. D., Alberola, I. D., Pinazo-Bandera, J. M., García‐Cortés, M., Sanabria‐Cabrera, J., Robles‐Díaz, M., Álvarez‐Álvarez, I., Lucena, M. I., Andrade, R. J., Paz, M. V., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70123 · Cited by 6
Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
Fidelle, M., Lebhar, I., Zitvogel, L., & Kroemer, G. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2224679 · Cited by 4
Self-citationMicroenvironment of Solid Tumors
Korneenko, T. V., Pestov, N. B., Shakhparonov, M. I., & Barlev, N. A. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36940 · Cited by 3
Soil and Seed: Tumor Microenvironment Nurtures Immunotherapy Resistance and Renewal
Li, Y., Feng, Q., Xia, Y., Liao, L., & Xie, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110547 · Cited by 6
Modeling TCR-pMHC Binding with Dual Encoders and Cross-Attention Fusion
Wang, W., Qi, C., & Wei, Z. (2025) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm66473.2025.11356540 · Cited by 7
Targeting the gut-lung axis in COPD: from microbial metabolites to fecal microbiota transplantation
Yu, Z., Qian, W., & Chu, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1798150 · Cited by 5
Gut microbiota and metabolic control of immune checkpoint blockade in cancer
Gladstone, J. L., & Sonnenberg, G. F. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.04.018 · Cited by 4
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy
Varende, A.-L. M. D. L., Tian, A.-L., Thomas, S., Lahmar, I., Messaoudene, M., Li, S., Motiño, O., Guillaume-dit-Taunière, H., Iebba, V., Hurtado, Y., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.022 · Cited by 5
Self-citationConti, B. D. P., Marino, R., Rezzonico-Jost, T., Forcato, M., Mangani, D., Notario, E., Gargari, G., Carelli, E., Rinaldi, A., Raimondi, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.aeb5308 · Cited by 3
Zitvogel, L., & Kroemer, G. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1484 · Cited by 2
Self-citationEffects of capsaicin on intestinal health under antibiotic exposure
Fang, Q., Yu, L., Tian, F., Chen, W., & Zhai, Q. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250311 · Cited by 2
Yu, C., Pan, Y., Mao, A., Zhao, Y., Liu, Q., & Hu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13112659 · Cited by 4
Routy, B., Rafie, E., & Elkrief, A. (2025) · Nature Cancer · doi:10.1038/s43018-025-01055-5 · Cited by 5
Self-citationPetouhoff, A., Hicks, R., Husain, M., Hoyd, R., Xu, M., Dravillas, C. E., Patel, S. H., Johns, A. C., Grogan, M. M., Li, M., et al. (2026) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-026-04346-7 · Cited by 2
The lethal symbiont: exploring the pathophysiology of cancer
Nolan, E., Li, L., Giampazolias, E., Ombrato, L., & Malanchi, I. (2026) · Physiological Reviews · doi:10.1152/physrev.00019.2025 · Cited by 2
The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities
Huang, J., Zhu, X.-H., Trotman, L. C., & Tsao, C. (2026) · Cancers · doi:10.3390/cancers18060998 · Cited by 4
LANTERN: TCR-peptide binding prediction via large language model representations
Qi, C., Fang, H., Jiang, S., Hu, T., & Wei, Z. (2026) · PeerJ · doi:10.7717/peerj.20980 · Cited by 11
Cheng, Y. D., Deng, W., Liu, Y., Chen, G., & Cao, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1802404 · Cited by 2
Yang, K., Zhang, Y., Xiong, J., Ai, B., Han, D., & Chong, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083678 · Cited by 2
Cheng, C. H., & Wong, C. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02698-3 · Cited by 2
The relationship between gut microbiota and cancer immune response and immunotherapy
Jia, Y., Liu, Y., & Liu, J. Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1833138 · Cited by 2
Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response
Golshani, M., Taylor, J. A., & Woolbright, B. L. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.07.004 · Cited by 4
Deng, F., Ye, H., Zhang, P., Xu, J., Li, Y., Sun, M., & Yang, Z. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15492 · Cited by 3
Enterocloster undermine cancer immunotherapy
Taglialegna, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00929-8 · Cited by 1
Comtet-Marre, S., Chakoory, O., Rochette, E., Gallot, D., Merlin, É., Pons, M., & Peyret, P. (2024) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2024.04.006 · Cited by 2
Microbiome as a predictive biomarker in locally advanced rectal cancer
Mulet-Margalef, N., Abad, B. M., Martinez‐Balibrea, E., Mozo, J. L. M., Borgognone, A., & Obón‐Santacana, M. (2025) · Microbiome Research Reports · doi:10.20517/mrr.2024.85 · Cited by 1
Su, Y.-Z., Sun, T., Yang, Q., Liu, Y., Zhang, J., & Shan, A. (2026) · Food Research International · doi:10.1016/j.foodres.2025.118073
Liu, X., Chen, Z., Lu, Y., Wu, Y., Huang, Y., Zhang, Y., Li, M., & Feng, N. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1756107 · Cited by 1
Ziogas, D. C., Theocharopoulos, C., Martinos, A., Lyrarakis, G., Stefanou, D. T., Anastasopoulou, A. N., & Gogas, H. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01744-z · Cited by 2
A Microbial Lipid‐ATP Synthase Axis Fuels NK Cell Antitumor Activity
Yu, K., Sun, X., Ma, W., Yang, J., Sun, X., Zhang, L., Liu, Y., Ren, T., Wang, Q., Wang, J., et al. (2026) · Advanced Science · doi:10.1002/advs.202520095 · Cited by 1
Diop, K., Benlaïfaoui, M., Hunter, S., Méndez-Salazar, E. O., Hakozaki, T., Richard, C., Prifti, D. K., Kourtian, S., Proulx-Rocray, F., Naimi, S., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02419-4 · Cited by 4
Self-citationLuo, Z., Xu, D., Wang, Z., Wu, L., Ou, C., & Ou, Z. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102270 · Cited by 1
Revisiting heliomycin: Chemistry, biological activity, and perspectives for drug development
Buravchenko, G. I., Tikhomirov, A. S., & Shchekotikhin, A. E. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119060 · Cited by 1
Ali, H., Xie, B., Yang, J., & Nadeem, U. (2026) · Cancers · doi:10.3390/cancers18121948 · Cited by 1
Shi, Z., Wang, Y., Gu, Y., Zhu, M., Li, M., & Yu, Q. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00161 · Cited by 1
Metagenome analysis reveals multi-kingdom gut microbiota as diagnostic markers for colorectal cancer
Wang, X., Wang, J., Chen, W., Sun, J., Li, J. Z., & Hu, H. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1805055 · Cited by 1
Li, L., Chen, H., Yin, H., Shen, Y., Shen, F., Guo, Z., Zhai, B. Y., Wang, Y., Kong, W., Xu, G., et al. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03121-z · Cited by 1
Jiang, Z., Li, L., Long, Q., Guo, W., Wang, M., Li, X., Li, J., & Yi, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1815707 · Cited by 1
Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets
Lu, Y., Shao, D., Xiao, Y., Jiang, Y., & Shao, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02851-w · Cited by 5
Marjanovic, M., Maletin, N., Kukic, B. P., Nikolić, I., Petrović, N., Radić, J., Đurić, A., Knezevic, M., Dejanović, B., & Calic, V. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1907957 · Cited by 1
Cancer immunosurveillance by gut T cells
Pratt, B. M., & Milner, J. J. (2023) · Science · doi:10.1126/science.adi3357 · Cited by 1
Immunological Regulation of Gut-Tropic Immune Cells by Extracellular Vesicles
Matsuzaka, Y., & Yashiro, R. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2284887 · Cited by 1
Understanding the link between respiratory microbiota and asthma
Tian, C., Yuan, X., Li, X., & Li, Z. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.06.079 · Cited by 1
Targeting the Immune Checkpoint in Bladder Cancer
Mercinelli, C., Tateo, V., Crupi, E., Cigliola, A., & Necchi, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-68505-7_23 · Cited by 1
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Silveira, M. A. D., Rodrigues, R. R., & Trinchieri, G. (2025) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2024.10.005 · Cited by 3
Liu, S., & Zhang, Z. (2025) · Cancer Management and Research · doi:10.2147/cmar.s520098 · Cited by 2
Fang, G., Ni, M., Fan, Y., Ksiezarek, M., & Fang, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.608814 · Cited by 3
Modeling TCR–pMHC Binding with Dual Encoders and Cross-Attention FusionPreprint
Wang, W., Qi, C., & Wei, Z. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.01.691424 · Cited by 1
Wie die Darmflora den Erfolg von Krebsimmuntherapien bestimmt
(2023) · TumorDiagnostik & Therapie · doi:10.1055/a-2091-9758
Impact du microbiote intestinal dans les cancers colorectaux
Fidelle, M., Chen, J., Roberti, M. P., Kroemer, G., & Zitvogel, L. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.09.009
Self-citationPotential mechanisms of action of the gut microbiota in antitumour immunity and immunotherapyPreprint
Yin, Q., Ni, J., & Ying, J.-E. (2024) · doi:10.22541/au.170664260.07438524/v1
Tian, A.-L., Leduc, M., Fidelle, M., Zitvogel, L., Kroemer, G., & Kepp, O. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.01.007
Self-citationFadel, K., Siblany, L., Mohty, R., Stocker, N., Suner, L., Brissot, É., Banet, A., Sestili, S., Duléry, R., de Wyngaert, Z. V., et al. (2025) · HemaSphere · doi:10.1002/hem3.70074
Righetti, F., Massara, M., & Calcinotto, A. (2025) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-031-84065-4_8
Zhang, C., Wang, Y., Ruan, H., Verma, V., Xu, W., & Han, G. (2025) · Future Oncology · doi:10.1080/14796694.2025.2525067
Li, M., Su, P., Zhao, S., Cheng, G., Jones, N., Chian, K., Johns, N. B., Khorasanchi, A., Adeluola, A. A., Petouhoff, A., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.71058
The Emerging Role of Microbiome in Radiation Research
Alizadeh, P., Mojtahed, A., & Taghizadeh‐Hesary, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-95724-6_19
Seeger, A., Babbar, A., Eswaran, S., Adams, M., Muschaweck, M., Treichel, N. S., Clavel, T., Yin, G., Guillot, A., Scheuer, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.24.678237
Self-citationWang, Y. S., Wang, Q. Y., Moise, A. E., Syed, H. C., Malo, J., Soberano, S., Belkaïd, W., Messaoudene, M., Bélanger, K., Desîlets, A., et al. (2025) · Current Oncology · doi:10.3390/curroncol32110630
Self-citationMicroflora: a promising potential in the diagnosis and treatment of non-small cell lung cancer
Wang, L., Chi, Y., Min, Z., Jiang, J., Meng, Z., & Wang, Z. (2025) · International Journal of Clinical Oncology · doi:10.1007/s10147-025-02934-8
Metadata
- Authors
- Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., Pizzato, E., Birebent, R., Mbogning Fonkou, M. D., Zoppi, S., Reni, A., Dalban, C., Leduc, M., Ferrere, G., Durand, S., Ly, P., Silvin, A., Mulder, K., Dutertre, C.-A., Ginhoux, F., Yonekura, S., Roberti, M. P., Tidjani-Alou, M., Terrisse, S., Chen, J., Kepp, O., Schippers, A., Wagner, N., Suárez-Gosálvez, J., Kobold, S., Fahrner, J.-E., Richard, C., Bosq, J., Lordello, L., Vitali, G., Galleron, N., Quinquis, B., Le Chatelier, E., Blanchard, L., Girard, J.-P., Jarry, A., Gervois, N., Godefroy, E., Labarrière, N., Koschny, R., Daillère, R., Besse, B., Truntzer, C., Ghiringhelli, F., Coatnoan, N., Mhanna, V., Klatzmann, D., Drubay, D., Albiges, L., Thomas, A. M., Segata, N., Danlos, F.-X., Marabelle, A., Routy, B., Derosa, L., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Gustave Roussy Cancer Campus, Villejuif Cedex, France.
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Parma (IT)
- University of Verona (IT)
- Centre Léon Bérard (FR)
- Universitätsklinikum Aachen (DE)
- Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
- Center for Integrated Protein Science Munich (DE)
- JBO Consultant, Paris, France.
- Université Paris-Saclay (FR)
- MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- Institut Gustave Roussy (FR)
- University of Trento (IT)
- Corresponding author
- Fidelle, Marine
- Rauber, Conrad
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fidelle, Marine
- Rauber, Conrad
- Alves Costa Silva, Carolina
- Tian, Ai-Ling
- Zhao, Liwei
- Messaoudene, Meriem
- Birebent, Roxanne
- Mbogning Fonkou, Maxime Descartes
- Zoppi, Silvia
- Reni, Anna
- Dalban, Cécile
- Leduc, Marion
- Ferrere, Gladys
- Durand, Sylvère
- Ly, Pierre
- Silvin, Aymeric
- Mulder, Kevin
- Dutertre, Charles-Antoine
- Ginhoux, Florent
- Yonekura, Satoru
- Roberti, Maria Paula
- Tidjani-Alou, Maryam
- Terrisse, Safae
- Chen, Jianzhou
- Kepp, Oliver
- Schippers, Angela
- Wagner, Norbert
- Suárez-Gosálvez, Javier
- Kobold, Sebastian
- Fahrner, Jean-Eudes
- Richard, Corentin
- Bosq, Jacques
- Lordello, Leonardo
- Galleron, Nathalie
- Quinquis, Benoît
- Le Chatelier, Emmanuelle
- Blanchard, Lucas
- Girard, Jean-Philippe
- Jarry, Anne
- Gervois, Nadine
- Godefroy, Emmanuelle
- Labarrière, Nathalie
- Koschny, Ronald
- Daillère, Romain
- Besse, Benjamin
- Truntzer, Caroline
- Ghiringhelli, François
- Coatnoan, Nicolas
- Mhanna, Vanessa
- Klatzmann, David
- Drubay, Damien
- Albiges, Laurence
- Thomas, Andrew Maltez
- Segata, Nicola
- Danlos, François-Xavier
- Marabelle, Aurélien
- Routy, Bertrand
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2023-06-09
- Volume
- 380
- Issue
- 6649
- Pages
- eabo2296-eabo2296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4379780265
- Cited by
- 243
- References
- 83
- Citations by year
- 2026: 74 · 2025: 86 · 2024: 58 · 2023: 25
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-16-RHUS-0001, ANR-21-ESRE-0028, ANR-18-IBHU-0002, ANR-19-CE15-0029, ANR-21-RHUS-0017, ANR-18-IDEX-0001)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- antibiotics, gut microbiota, MAdCAM-1, alpha4beta7 integrin, regulatory T cells, anti-PD-1 therapy, tumor immunosuppression, Enterocloster, fecal microbiota transplantation, IL-17A, prognostic factors, lung cancer, kidney cancer, bladder cancer
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, Animals, Anti-Bacterial Agents, Bacteria, Cell Movement, Humans, Immune Tolerance, Immunologic Surveillance, Mucoproteins, Neoplasms, Cell Adhesion Molecules, Integrins, Drug Resistance, Neoplasm, Interleukin-17, Gastrointestinal Tract, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.